化学抗原受体-T细胞治疗T细胞衍生的血液性恶性瘤
Haiqiong Zheng1,2,3, Houli Zhao1,2,3, Shi Han1,2,3
1Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.
Experimental hematology & oncology
|November 28, 2024
概括
化学抗原受体 (CAR) -T细胞疗法在治疗T细胞恶性瘤方面面临挑战,原因是T细胞相似性,导致诸如兄弟杀戮和无形性等问题. 本综述探讨了改善T细胞癌的CAR-T细胞疗法的当前局限性和策略.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法 细胞疗法
背景情况:
- 来自T细胞的恶性瘤是异质的,预后不佳.
- 化学抗原受体 (CAR) -T细胞疗法对B细胞恶性瘤有效,但在T细胞癌症中面临挑战.
- 正常和恶性T细胞之间的相似性导致诸如兄弟杀伤和T细胞无形成等问题.
研究的目的:
- 审查CAR-T细胞治疗T细胞衍生的恶性瘤的当前挑战.
- 讨论潜在的策略来克服治疗这些癌症的局限性.
主要方法:
- 审查现有的临床试验数据和关于治疗T细胞恶性瘤的CAR-T细胞疗法的文献.
- 限制的分析包括兄弟杀戮,T细胞无形成,瘤污染和免疫缺陷.
- 探索全基性CAR-T细胞和基因编辑策略.
主要成果:
- 泛T抗原CAR-T细胞 (例如,向CD5,CD7) 显示广泛覆盖,但诱导CAR-T细胞和正常T细胞的死亡.
- 全基性CAR-T细胞提供了通用产品,并防止瘤污染,但不能完全防止免疫缺陷或复发.
- 目前的CAR-T细胞疗法不能完全预防免疫缺陷和疾病复发.
结论:
- 对于T细胞恶性瘤的CAR-T细胞疗法仍然存在重大挑战.
- 需要进一步的策略来提高有效性和安全性,解决兄弟杀戮,无育症和复发问题.
- 基因编辑和异构方法的进步是有希望的,但需要进一步发展.
更多相关视频
08:46A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
53.2K
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
461
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
